Noa Avisar

Dr. Avisar has 20 years of experience in drug and device development. She led the clinical development of oncology and neurology projects at Teva Pharmaceuticals, and was the full project development leader in oncology, psychiatry, autoimmunology, HIV and biological drugs from early to late stages. Dr. Avisar has published 13 papers in scientific journals. She holds a Ph.D. in molecular biology from Tel Aviv University with a post-doctorate research in molecular immunobiology from University of California Santa Barbara, USA.